Evidence map›Paper›PMID 42325588›Full record

ArticleiScience2026

Genome instability is increased during DNA replication in the presence of the CPD UV photoproduct in transcriptionally active genes.

Rika Kusumoto-Matsuo, Yusuke Matsuno, Naoki Akiba, Yuya Manaka, Jiro Toshima, Fumio Hanaoka, Ken-Ichi Yoshioka

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rika Kusumoto-MatsuoLaboratory of Genome Stability Maintenance, Research Institute, National Cancer Center Japan, Tsukiji, Chuo-ku, Tokyo, Japan.
Yusuke MatsunoLaboratory of Genome Stability Maintenance, Research Institute, National Cancer Center Japan, Tsukiji, Chuo-ku, Tokyo, Japan.
Naoki AkibaLaboratory of Genome Stability Maintenance, Research Institute, National Cancer Center Japan, Tsukiji, Chuo-ku, Tokyo, Japan.
Yuya ManakaLaboratory of Genome Stability Maintenance, Research Institute, National Cancer Center Japan, Tsukiji, Chuo-ku, Tokyo, Japan.
Jiro ToshimaDepartment of Biological Science and Technology, Tokyo University of Science, Niijuku, Katsushika-ku, Tokyo, Japan.
Fumio HanaokaNational Institute of Genetics, Mishima, Shizuoka, Japan.
Ken-Ichi YoshiokaLaboratory of Genome Stability Maintenance, Research Institute, National Cancer Center Japan, Tsukiji, Chuo-ku, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ultraviolet (UV) light primarily induces cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone (6-4) photoproducts (6-4 PPs) and increases the risk of melanoma developing with genome instability. Here, we show that DNA double-strand breaks (DSBs) associated with genome instability arise during DNA replication in the presence of CPDs. Whereas 6-4PPs, which induce γH2AX expression and cell-cycle arrest, are repaired before the onset of DNA replication, CPDs persist into S phase. We also show that these DSBs are induced in association with transcription-coupled nucleotide excision repair (TC-NER). These DSBs decrease after CPDs were partially repaired in active chromatin regions, but persist in inactive chromatin regions. Structure variants (SVs) and single nucleotide variants (SNVs) associated with the UV-related single-base substitution 7 (SBS7) signature are induced in UV-irradiated cells. Our results point to a pathway that may underlie the genomic alterations observed in human melanoma.

Indexed as

cancercell biologymolecular biology

Identifiers

PMID42325588
PMCPMC13276455

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.